The University of Texas MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
The University of Texas MD Anderson Cancer Center has participated in 673 clinical trials with 260 currently active.
Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC).
Sponsors: Pfizer, Kestrel Therapeutics, Inc., pharmaand GmbH.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Houston
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Texas MD Anderson Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Texas MD Anderson Cancer Center has 673 clinical trials on record, with 260 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC).
The University of Texas MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.